2024 Q3 Form 10-Q Financial Statement

#000121390024080355 Filed on September 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $96.31K $223.1K
YoY Change 56.39% -3776.11%
Cost Of Revenue $285.00 $22.73K $1.339M
YoY Change -98.93%
Gross Profit $96.02K -$22.73K -$1.116M
YoY Change 175.01% 18279.24%
Gross Profit Margin 99.7% -499.96%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $36.71K
YoY Change -93.08%
% of Gross Profit
Depreciation & Amortization $34.40K $1.367M
YoY Change -88.14% 369.15%
% of Gross Profit
Operating Expenses $3.687M $6.446M $4.253M
YoY Change -14.34% 77.31% -2.22%
Operating Profit -$3.591M -$6.469M -$5.368M
YoY Change -15.88% 77.93% 23.25%
Interest Expense -$447.6K $982.9K
YoY Change -117.21% -0.33%
% of Operating Profit
Other Income/Expense, Net -$101.6K -$442.6K -$582.6K
YoY Change -95.29% -119.49% 155.88%
Pretax Income -$3.692M -$6.912M -$9.529M
YoY Change -42.52% 406.53% 233.55%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.692M -$6.912M -$9.529M
YoY Change -42.52% 405.64% 233.4%
Net Earnings / Revenue -3833.94% -4270.23%
Basic Earnings Per Share -$0.20 -$0.39
Diluted Earnings Per Share -$0.20 -$0.39 -$0.56
COMMON SHARES
Basic Shares Outstanding 18.35M shares 17.96M shares 9.869M shares
Diluted Shares Outstanding 18.35M shares 17.90M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.156M $8.008M
YoY Change -81.17% -9.9%
Cash & Equivalents $77.03K $78.50K $7.429M
Short-Term Investments $1.092M $3.805M
Other Short-Term Assets $73.11K $69.23K $65.94K
YoY Change -51.23% -95.36% -99.18%
Inventory $190.4K $170.9K $170.9K
Prepaid Expenses $291.7K $287.3K $158.2K
Receivables $0.00 $41.09K
Other Receivables $398.6K $2.337M $122.0K
Total Short-Term Assets $6.043M $7.380M $9.734M
YoY Change -64.07% -56.82% -48.06%
LONG-TERM ASSETS
Property, Plant & Equipment $41.80M $40.86M $42.79M
YoY Change 17.89% 10.87% 13.13%
Goodwill $4.574M $4.574M $4.574M
YoY Change -78.46% 0.28% 0.28%
Intangibles $11.71M $12.14M $13.02M
YoY Change 1035.46% 950.82% 828.68%
Long-Term Investments $4.731M $4.262M
YoY Change 12.91% -6.79%
Other Assets $28.18M $27.79M $5.837M
YoY Change 369.46% 360.88% -28.04%
Total Long-Term Assets $74.83M $73.38M $79.03M
YoY Change 10.01% 38.3% 52.28%
TOTAL ASSETS
Total Short-Term Assets $6.043M $7.380M $9.734M
Total Long-Term Assets $74.83M $73.38M $79.03M
Total Assets $80.88M $80.76M $88.77M
YoY Change -4.67% 15.13% 25.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.901M $1.892M $1.900M
YoY Change 21.48% 10.87% -2.59%
Accrued Expenses $7.956M $6.599M $18.77M
YoY Change -48.76% -51.73% 634.97%
Deferred Revenue $762.0K $762.0K
YoY Change
Short-Term Debt $5.547M $5.512M $132.3K
YoY Change 464.59% 314.0% -89.95%
Long-Term Debt Due $6.670K $5.045K
YoY Change -37.41% -77.2%
Total Short-Term Liabilities $61.63M $58.70M $28.08M
YoY Change 191.54% 250.95% 125.38%
LONG-TERM LIABILITIES
Long-Term Debt $200.0K
YoY Change
Other Long-Term Liabilities $80.42K $120.9K
YoY Change -91.35% -84.61%
Total Long-Term Liabilities $290.8K $280.4K $33.71M
YoY Change -99.14% -99.16% 1.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $61.63M $58.70M $28.08M
Total Long-Term Liabilities $290.8K $280.4K $33.71M
Total Liabilities $61.92M $58.98M $61.79M
YoY Change 12.96% 17.44% 35.58%
SHAREHOLDERS EQUITY
Retained Earnings -$94.17M -$90.47M -$74.72M
YoY Change 44.45% 53.95% 39.28%
Common Stock $18.20K $18.20K $16.72K
YoY Change 8.87% 87.27% 72.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.96M $21.78M $26.98M
YoY Change
Total Liabilities & Shareholders Equity $80.88M $80.76M $88.77M
YoY Change -4.67% 15.13% 25.66%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$3.692M -$6.912M -$9.529M
YoY Change -42.52% 405.64% 233.4%
Depreciation, Depletion And Amortization $34.40K $1.367M
YoY Change -88.14% 369.15%
Cash From Operating Activities -$2.304M $7.895M
YoY Change 145.13% -312.55%
INVESTING ACTIVITIES
Capital Expenditures -$5.730K $5.951M
YoY Change -128.65% 359.52%
Acquisitions
YoY Change
Other Investing Activities -$900.4K $0.00
YoY Change -100.0%
Cash From Investing Activities -$894.7K -$5.951M
YoY Change 2882.33% 342.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.053M 4.065M
YoY Change -507.09% -59.39%
NET CHANGE
Cash From Operating Activities -2.304M 7.895M
Cash From Investing Activities -894.7K -5.951M
Cash From Financing Activities 3.053M 4.065M
Net Change In Cash -145.7K 6.009M
YoY Change -91.53% 21.3%
FREE CASH FLOW
Cash From Operating Activities -$2.304M $7.895M
Capital Expenditures -$5.730K $5.951M
Free Cash Flow -$2.298M $1.944M
YoY Change 139.43% -138.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
usd
dei Entity Registrant Name
EntityRegistrantName
AERKOMM INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3424568
dei Entity Address Address Line1
EntityAddressAddressLine1
44043 Fremont Blvd
dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94538
dei City Area Code
CityAreaCode
(877)
dei Local Phone Number
LocalPhoneNumber
742-3094
dei Security12b Title
Security12bTitle
None
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18352613 shares
CY2024Q2 us-gaap Cash
Cash
63740 usd
CY2023Q4 us-gaap Cash
Cash
4202797 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
1092414 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1156875 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
170892 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
170892 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
287258 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
158171 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2337276 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
122024 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
69231 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
65937 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
7380208 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
8065285 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
4731064 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
5013814 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5345065 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5381203 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3152624 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3085789 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
2192441 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
2295414 usd
CY2024Q2 us-gaap Land
Land
38346669 usd
CY2023Q4 us-gaap Land
Land
40114286 usd
CY2024Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
317639 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
324866 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40856749 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42734566 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
8406433 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
8326017 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
14755 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
3225905 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12136934 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13024692 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4573819 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4573819 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162142 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
221417 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
52327 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
55454 usd
CY2024Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
368115 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
534515 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27791130 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32037957 usd
CY2024Q2 us-gaap Assets
Assets
80759151 usd
CY2023Q4 us-gaap Assets
Assets
87851622 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
5512037 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5712244 usd
CY2024Q2 akom Convertible Longterm Bonds Payable Current
ConvertibleLongtermBondsPayableCurrent
2537349 usd
CY2023Q4 akom Convertible Longterm Bonds Payable Current
ConvertibleLongtermBondsPayableCurrent
10303775 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
23173200 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
23173200 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1892480 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1900317 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6598518 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5995972 usd
CY2024Q2 akom Other Payable Related Parties
OtherPayableRelatedParties
781934 usd
CY2023Q4 akom Other Payable Related Parties
OtherPayableRelatedParties
726802 usd
CY2024Q2 akom Other Payable Current
OtherPayableCurrent
11369618 usd
CY2023Q4 akom Other Payable Current
OtherPayableCurrent
8057112 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
762000 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
5045 usd
CY2024Q2 akom Lease Liability Current
LeaseLiabilityCurrent
167001 usd
CY2023Q4 akom Lease Liability Current
LeaseLiabilityCurrent
168433 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58696603 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62577808 usd
CY2024Q2 us-gaap Long Term Transition Bond
LongTermTransitionBond
200000 usd
CY2023Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
200000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
762000 usd
CY2024Q2 akom Lease Liability Noncurrent
LeaseLiabilityNoncurrent
79416 usd
CY2023Q4 akom Lease Liability Noncurrent
LeaseLiabilityNoncurrent
120932 usd
CY2024Q2 akom Restricted Stock Deposit Liability
RestrictedStockDepositLiability
1000 usd
CY2023Q4 akom Restricted Stock Deposit Liability
RestrictedStockDepositLiability
1000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
280416 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1083932 usd
CY2024Q2 us-gaap Liabilities
Liabilities
58977019 usd
CY2023Q4 us-gaap Liabilities
Liabilities
63661740 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18203451 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18203451 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16720451 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16720451 shares
CY2024Q2 akom Restricted Stock Shares
RestrictedStockShares
149162 shares
CY2023Q4 akom Restricted Stock Shares
RestrictedStockShares
149162 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
18203 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
16720 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109956218 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97015470 usd
CY2024Q2 akom Subscribed Capital
SubscribedCapital
3499496 usd
CY2023Q4 akom Subscribed Capital
SubscribedCapital
5004000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90473956 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77479704 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1217829 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-366604 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
21782132 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24189882 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80759151 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87851622 usd
us-gaap Revenues
Revenues
53255 usd
us-gaap Revenues
Revenues
451915 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
22727 usd
us-gaap Cost Of Revenue
CostOfRevenue
60843 usd
us-gaap Cost Of Revenue
CostOfRevenue
445449 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
-22727 usd
us-gaap Gross Profit
GrossProfit
-7588 usd
us-gaap Gross Profit
GrossProfit
6466 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
6446335 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3635725 usd
us-gaap Operating Expenses
OperatingExpenses
11554437 usd
us-gaap Operating Expenses
OperatingExpenses
7279117 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6469062 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3635725 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11562025 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7272651 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-141664 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-499732 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-830259 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-320143 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
305994 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
365443 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
592625 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
726650 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55925
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
108 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-95686 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
780 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-103515 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4933 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37470 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7723 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
109407 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-442617 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-923391 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1429827 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1040901 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6911679 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4559116 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12991852 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8313552 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6911679 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4561516 usd
us-gaap Net Income Loss
NetIncomeLoss
-12994252 usd
us-gaap Net Income Loss
NetIncomeLoss
-8315952 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-181989 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-356188 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-851225 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-221934 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7093668 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4917704 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13845477 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8537886 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17900921 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9869165 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17900921 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9869165 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17900921 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9869165 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17900921 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9869165 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
25067770 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54891 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
134254 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3754436 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21502479 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
209995 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-356188 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4561516 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16794770 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24189882 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1554000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
633048 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-669236 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6082573 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
19625121 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2340000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3499496 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3411183 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-181989 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6911679 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
21782132 usd
us-gaap Net Income Loss
NetIncomeLoss
-12994252 usd
us-gaap Net Income Loss
NetIncomeLoss
-8315952 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1024772 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
606747 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
63539 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43658 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4044230 usd
us-gaap Share Based Compensation
ShareBasedCompensation
264886 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
780 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-103515 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
252021 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41088 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2562695 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3342273 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-166400 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
239257 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7837 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-243963 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4362101 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4837127 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
21710 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21231 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5841724 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6054722 usd
us-gaap Payments To Acquire Land Held For Use
PaymentsToAcquireLandHeldForUse
340524 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
1231799 usd
us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
-325578 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
11094 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
364164 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1583417 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38586 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
944686 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
15145 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1948100 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
837871 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4843 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5642 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
7766426 usd
akom Proceeds From Subscribed Capital
ProceedsFromSubscribedCapital
-4421782 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5381 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5817 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1299953 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3686 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8725094 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6089622 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7428702 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10101920 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1374887 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338698 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78495 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4350996 usd
us-gaap Interest Paid Net
InterestPaidNet
592625 usd
CY2024Q2 us-gaap Cash
Cash
63740 usd
CY2023Q2 us-gaap Cash
Cash
1125988 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
14755 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
3225008 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78495 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4350996 usd
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.863 pure
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.997 pure
CY2022Q4 akom Majority Interest
MajorityInterest
25500000 shares
CY2022Q4 akom Taiwan Buyer
TaiwanBuyer
255000000 twd
CY2022 akom Taiwan Buyer
TaiwanBuyer
8300000 usd
CY2024Q2 us-gaap Bridge Loan
BridgeLoan
10000000 usd
akom Aggregate Principal Amount
aggregatePrincipalAmount
20000000 usd
akom Principal Loan Percentage
PrincipalLoanPercentage
0.25 pure
CY2024Q2 akom Working Capital
WorkingCapital
20000000 usd
CY2024Q2 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.05 pure
CY2023Q4 us-gaap Cash
Cash
4202797 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1156875 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
170892 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
158171 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
122024 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
65937 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
8065285 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
5013814 usd
CY2023Q4 akom Property Plant And Equipment Cost
PropertyPlantAndEquipmentCost
5381203 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3085789 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
2295414 usd
CY2023Q4 us-gaap Land
Land
40114286 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
324866 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42734566 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
8326017 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
3225905 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13024692 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4573819 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
221417 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
55454 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
534515 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32037957 usd
CY2023Q4 us-gaap Assets
Assets
87851622 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5712244 usd
CY2023Q4 akom Convertible Longterm Bonds Payable Current
ConvertibleLongtermBondsPayableCurrent
10303775 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
23173200 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1900317 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5995972 usd
CY2023Q4 akom Other Payable Related Parties
OtherPayableRelatedParties
726802 usd
CY2023Q4 akom Other Payable Current
OtherPayableCurrent
8057112 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
5045 usd
CY2023Q4 akom Lease Liability Current
LeaseLiabilityCurrent
168433 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62577808 usd
CY2023Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
200000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
762000 usd
CY2023Q4 akom Lease Liability Noncurrent
LeaseLiabilityNoncurrent
120932 usd
CY2023Q4 akom Restricted Stock Deposit Liability
RestrictedStockDepositLiability
1000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1083932 usd
CY2023Q4 us-gaap Liabilities
Liabilities
63661740 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16720451 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16720451 shares
CY2023Q4 akom Restricted Stock Shares
RestrictedStockShares
149162 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
16720 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97015470 usd
CY2023Q4 akom Subscribed Capital
SubscribedCapital
5004000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77479704 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-366604 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
24189882 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87851622 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3635725 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3635725 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-499732 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
365443 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-95686 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37470 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-923391 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4559116 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4561516 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-356188 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4917704 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9869165 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9869165 shares
us-gaap Revenues
Revenues
451915 usd
us-gaap Cost Of Revenue
CostOfRevenue
445449 usd
us-gaap Gross Profit
GrossProfit
6466 usd
us-gaap Operating Expenses
OperatingExpenses
7279117 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7272651 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-320143 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
726650 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-103515 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
109407 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1040901 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8313552 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
us-gaap Net Income Loss
NetIncomeLoss
-8315952 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-221934 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8537886 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9869165 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9869165 shares
us-gaap Net Income Loss
NetIncomeLoss
-8315952 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
606747 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
43658 usd
us-gaap Share Based Compensation
ShareBasedCompensation
264886 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-103515 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
252021 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3342273 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
239257 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-243963 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4837127 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21231 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6054722 usd
us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
-325578 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
364164 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38586 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
15145 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5642 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5817 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3686 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6089622 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10101920 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338698 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4350996 usd
CY2023Q2 us-gaap Cash
Cash
1125988 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
3225008 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4350996 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration:underline">Reclassifications of Prior Year Presentation </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain prior year balance sheet, and cash flow statement amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results may differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 7pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration:underline">Concentrations of Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash in banks. As of June 30, 2024 and December 31, 2023, the total balance of cash in bank exceeding the amount insured by the Federal Deposit Insurance Corporation (FDIC) for the Company was approximately $0 and $0, respectively.   The balance of cash deposited in foreign financial institutions exceeding the amount insured by local insurance is approximately $44,000 and $7,246,000 as of June 30, 2024 and December 31, 2023, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company performs ongoing credit evaluation of its customers and requires no collateral. An allowance for doubtful accounts is provided based on a review of the collectability of accounts receivable. The Company determines the amount of allowance for doubtful accounts by examining its historical collection experience and current trends in the credit quality of its customers as well as its internal credit policies. Actual credit losses may differ from management’s estimates.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
0 usd
CY2023 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
0 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 usd
akom Translationadjustmentspolicytextblock
Translationadjustmentspolicytextblock
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration:underline">Translation Adjustments</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If a foreign subsidiary’s functional currency is the local currency, translation adjustments will result from the process of translating the subsidiary’s financial statements into the reporting currency of the Company. Such adjustments are accumulated and reported under other comprehensive loss as a separate component of stockholders’ equity.</p>
CY2019Q3 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
225500 usd
CY2019Q3 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
200000 eur
CY2019Q3 akom Annual Compensation Amount
AnnualCompensationAmount
20000 eur
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
780 usd
CY2022Q3 akom Value Of Purchase Common Stock Amount
ValueOfPurchaseCommonStockAmount
35000000 twd
akom Value Of Purchase Common Stock Amount
ValueOfPurchaseCommonStockAmount
1078583 usd
CY2023 akom Value Of Purchase Common Stock Amount
ValueOfPurchaseCommonStockAmount
1143044 usd
CY2024Q2 akom Investment Liquidity
InvestmentLiquidity
13831 usd
CY2023Q4 akom Investment Liquidity
InvestmentLiquidity
13831 usd
CY2024Q2 akom Prepaid Investment
PrepaidInvestment
1078583 usd
CY2023Q4 akom Prepaid Investment
PrepaidInvestment
1143044 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
1092414 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1156875 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
170892 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
170892 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
1327788 usd
CY2024Q2 akom Prepaid Professional Expense
PrepaidProfessionalExpense
118566 usd
CY2023Q4 akom Prepaid Professional Expense
PrepaidProfessionalExpense
110043 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
168692 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
48128 usd
CY2024Q2 akom Prepaid Expenses And Prepayments For Equipment And Intangible Assets
PrepaidExpensesAndPrepaymentsForEquipmentAndIntangibleAssets
287258 usd
CY2023Q4 akom Prepaid Expenses And Prepayments For Equipment And Intangible Assets
PrepaidExpensesAndPrepaymentsForEquipmentAndIntangibleAssets
158171 usd
CY2024Q2 akom Prepayment For Equipment And Intangible Assets Customer Projects Related Parties
PrepaymentForEquipmentAndIntangibleAssetsCustomerProjectsRelatedParties
2076605 usd
CY2023Q4 akom Prepayment For Equipment And Intangible Assets Customer Projects Related Parties
PrepaymentForEquipmentAndIntangibleAssetsCustomerProjectsRelatedParties
2076138 usd
CY2024Q2 akom Prepayment For Equipment And Intangible Assets Customer Projects
PrepaymentForEquipmentAndIntangibleAssetsCustomerProjects
8406433 usd
CY2023Q4 akom Prepayment For Equipment And Intangible Assets Customer Projects
PrepaymentForEquipmentAndIntangibleAssetsCustomerProjects
8326017 usd
CY2024Q2 akom Refundable Prepayments
RefundablePrepayments
1098549407 twd
CY2024Q2 akom Refundable Prepayments
RefundablePrepayments
33853603 usd
CY2023Q4 akom Refundable Prepayments
RefundablePrepayments
35876859 usd
CY2024Q2 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
42251900 twd
CY2024Q2 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
1302062 usd
CY2023Q4 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
1379879 usd
us-gaap Depreciation
Depreciation
142661 usd
us-gaap Depreciation
Depreciation
359247 usd
CY2024Q2 us-gaap Shares Held In Employee Stock Option Plan Committed To Be Released
SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased
6000000 shares
CY2023Q4 us-gaap Shares Held In Employee Stock Option Plan Committed To Be Released
SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased
6000000 shares
CY2024Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
5000000 shares
CY2024Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
25.58
CY2022Q3 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
40050000 twd
CY2022 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
1303287 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10005000 twd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
325578 usd
CY2022Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
667000 shares
CY2024Q2 akom Investment At Cost Ejectt Longterm
InvestmentAtCostEjecttLongterm
-4731064 usd
CY2023Q4 akom Investment At Cost Ejectt Longterm
InvestmentAtCostEjecttLongterm
-5013814 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
4731064 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
5013814 usd
CY2023Q4 akom Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
13024692 usd
akom Additional Accumulated Amortization Intangible Asset
AdditionalAccumulatedAmortizationIntangibleAsset
-882111 usd
akom Currency Translation Adjustment
CurrencyTranslationAdjustment
-5647 usd
CY2024Q2 akom Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
12136934 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
882111 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
247500 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
4561037 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4561037 usd
CY2023 akom Goodwill Addition
GoodwillAddition
4573819 usd
CY2023 akom Accumulated Impairment Addition
AccumulatedImpairmentAddition
4561037 usd
CY2023 akom Goodwill Addition Net
GoodwillAdditionNet
12782 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
9134856 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4561037 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4573819 usd
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
9134856 usd
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4561037 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4573819 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4561037 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4561037 usd
CY2023Q3 akom Ownership Percentage
OwnershipPercentage
1 pure
CY2023Q3 us-gaap Share Price
SharePrice
2.36
CY2023Q3 akom Acquisition Cost
AcquisitionCost
11926181 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
4573819 usd
CY2024Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5857545 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6598518 usd
akom Accrued Unpaid Salaries Settlement Percentage
AccruedUnpaidSalariesSettlementPercentage
0.40 pure
CY2024Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
3051000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M7D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M19D
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M6D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M6D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0382 pure
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0382 pure
akom Lease Expense
LeaseExpense
63539 usd
akom Lease Expense
LeaseExpense
43658 usd
us-gaap Sublease Income
SubleaseIncome
3942 usd
us-gaap Sublease Income
SubleaseIncome
26763 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
59597 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
16895 usd
akom Finance Lease Amortization Of Property And Equipment
FinanceLeaseAmortizationOfPropertyAndEquipment
5323 usd
akom Finance Lease Amortization Of Property And Equipment
FinanceLeaseAmortizationOfPropertyAndEquipment
5558 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
190 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
408 usd
akom Total Finance Lease Cost
TotalFinanceLeaseCost
5513 usd
akom Total Finance Lease Cost
TotalFinanceLeaseCost
5966 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
90179 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
81818 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
171997 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9855 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
162142 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
82726 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79416 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
6733 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6733 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
68 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
6665 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
6665 usd
CY2021Q2 akom Loan Agreement In The Amount
LoanAgreementInTheAmount
1433177 usd
CY2021Q2 akom Loan Agreement In The Amount
LoanAgreementInTheAmount
40000000 twd
CY2024Q2 akom Repaid Outstanding Loan
RepaidOutstandingLoan
924499 usd
CY2024Q2 akom Repaid Outstanding Loan
RepaidOutstandingLoan
30000000 twd
CY2021Q2 akom Collateralized Loan
CollateralizedLoan
3500000 shares
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
1500000 twd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
46978 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
48988 usd
CY2024Q2 us-gaap Long Term Debt Maturity Date
LongTermDebtMaturityDate
2024-05-21
akom Line Of Credit Facility Commitments Fee Percentage
LineOfCreditFacilityCommitmentsFeePercentage
0.097 pure
akom Installment Payment Description
InstallmentPaymentDescription
The installment payment plan is 60 months to pay off the balance on the 21st of each month.
CY2020Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.075 pure
akom Interest Of Percentage
InterestOfPercentage
0.075 pure
akom Redemptions Of Debt Description
RedemptionsOfDebtDescription
The Company has the option to redeem the Bonds at a redemption amount equal to the Early Redemption Amount, as defined in the Offering Memorandum, at any time on or after December 2, 2023 and prior to the Maturity Date, if the Closing Price of the Company’s Common Stock listed on the Euronext Paris for 20 trading days in any period of 30 consecutive trading days, the last day of which occurs not more than fifteen trading days prior to the date on which notice of such redemption is given, is greater than 130% of the Conversion Price on each applicable trading day or (ii) in whole or in part of the Bonds on the second anniversary of the issue date or (iii) where 90% or more in principal amount of the Bonds issued have been redeemed, converted or repurchased and cancelled.
CY2020Q4 akom Common Stock Convertible Par Or Stated Value Per Share
CommonStockConvertibleParOrStatedValuePerShare
0.001
us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
13.3
akom Shares Pledged As Collateral
SharesPledgedAsCollateral
2500000 shares
akom Total Repaid
TotalRepaid
7812247 usd
akom Principal And Interest
PrincipalAndInterest
10358024 usd
CY2024Q2 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
2612153 usd
CY2024Q2 akom Convertible Longterm Bonds Payable Current
ConvertibleLongtermBondsPayableCurrent
2537349 usd
CY2023Q4 akom Convertible Longterm Bonds Payable Current
ConvertibleLongtermBondsPayableCurrent
10303775 usd
CY2024Q2 us-gaap Long Term Transition Bond
LongTermTransitionBond
200000 usd
CY2023Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
200000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
252021 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
74804 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
40070 usd
CY2022Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
3175200 usd
CY2022Q3 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
5674000 usd
CY2022Q4 akom Common Stock Total Subscriptions Value
CommonStockTotalSubscriptionsValue
13173200 usd
CY2024Q2 us-gaap Other Additional Capital
OtherAdditionalCapital
10000000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
30000000 usd
CY2024Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.04 pure
CY2024Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
6
CY2015Q1 akom Purchase Agreement Terms
PurchaseAgreementTerms
P10Y
CY2015Q1 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
909000 usd
CY2023Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2400 usd
CY2023Q2 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
2400 usd
us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
2400 usd
us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
2400 usd
CY2024Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-932038 usd
CY2023Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1064777 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2788385 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1707582 usd
CY2024Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9653 usd
CY2023Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
550540 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1376152 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1559414 usd
CY2024Q2 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
158141 usd
CY2023Q2 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
296363 usd
us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
274837 usd
us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
156170 usd
CY2024Q2 akom Stockbased Compensation Expense
StockbasedCompensationExpense
714400 usd
CY2023Q2 akom Stockbased Compensation Expense
StockbasedCompensationExpense
28200 usd
akom Stockbased Compensation Expense
StockbasedCompensationExpense
849300 usd
akom Stockbased Compensation Expense
StockbasedCompensationExpense
39700 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34400 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66800 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68400 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
85700 usd
CY2024Q2 akom Accrued Payroll
AccruedPayroll
-4100 usd
CY2023Q2 akom Accrued Payroll
AccruedPayroll
-82700 usd
akom Accrued Payroll
AccruedPayroll
-113700 usd
akom Accrued Payroll
AccruedPayroll
-114300 usd
CY2024Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
7444 usd
CY2023Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
36274 usd
us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
98696 usd
us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-237002 usd
CY2024Q2 akom Deferred Costs Gross Other
DeferredCostsGrossOther
3900 usd
CY2023Q2 akom Deferred Costs Gross Other
DeferredCostsGrossOther
6300 usd
akom Deferred Costs Gross Other
DeferredCostsGrossOther
9700 usd
akom Deferred Costs Gross Other
DeferredCostsGrossOther
-8300 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17487000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14831000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4634000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3502000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1051000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
889000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
68000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
68000 usd
CY2024Q2 akom Unrealized Exchanges Losses
UnrealizedExchangesLosses
120000 usd
CY2023Q4 akom Unrealized Exchanges Losses
UnrealizedExchangesLosses
20000 usd
CY2024Q2 akom Excess Of Tax Amortization Over Book Amortization
ExcessOfTaxAmortizationOverBookAmortization
-181000 usd
CY2023Q4 akom Excess Of Tax Amortization Over Book Amortization
ExcessOfTaxAmortizationOverBookAmortization
-285000 usd
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
58000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
27000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23237000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19052000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23237000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19052000 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4185000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1802373 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1802373 shares
akom Share Based Compensation Arrangement By Sharebased Payment Award Option Nonvested Number Of Shares
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares
149162 shares
CY2023 akom Share Based Compensation Arrangement By Sharebased Payment Award Option Nonvested Number Of Shares
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares
149162 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1951535 shares
CY2023 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1951535 shares
CY2024Q2 akom Due To Other Related Parties Current And Noncurrents
DueToOtherRelatedPartiesCurrentAndNoncurrents
781934 usd
CY2023Q4 akom Due To Other Related Parties Current And Noncurrents
DueToOtherRelatedPartiesCurrentAndNoncurrents
726802 usd
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
us-gaap Other Expenses
OtherExpenses
6820000 jpy
CY2022 us-gaap Other Expenses
OtherExpenses
51800 usd
CY2023Q4 akom Sales Agreements
SalesAgreements
1243247 usd
CY2024Q2 akom Sales Agreements
SalesAgreements
1173135 usd
CY2023Q3 us-gaap Security Deposit
SecurityDeposit
20000000 twd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
653168 usd
CY2024Q2 us-gaap Security Deposit
SecurityDeposit
616333 usd
us-gaap Equipment Expense
EquipmentExpense
3793306 usd
CY2023Q4 us-gaap Equipment Expense
EquipmentExpense
5333333 twd
CY2023 us-gaap Equipment Expense
EquipmentExpense
174178 usd
CY2021 akom Consulting Fees
ConsultingFees
15120 eur
CY2021 akom Consulting Fees
ConsultingFees
17000 usd
CY2023Q4 us-gaap Longterm Construction Loan Current And Noncurrent
LongtermConstructionLoanCurrentAndNoncurrent
75326 usd
CY2023Q4 us-gaap Longterm Construction Loan Current And Noncurrent
LongtermConstructionLoanCurrentAndNoncurrent
2306000 twd
CY2024Q1 us-gaap Longterm Construction Loan Current And Noncurrent
LongtermConstructionLoanCurrentAndNoncurrent
155285 usd
CY2024Q1 us-gaap Longterm Construction Loan Current And Noncurrent
LongtermConstructionLoanCurrentAndNoncurrent
5039006 twd
CY2017Q2 akom Vest Rate Percentage
VestRatePercentage
0.50 pure
CY2017Q3 us-gaap Shares Acquired Weighted Average Discount To Net Assets Percentage
SharesAcquiredWeightedAverageDiscountToNetAssetsPercentage
0.50 pure
CY2017Q4 akom Independent Directors Shares
IndependentDirectorsShares
4000 shares
CY2018Q4 akom Independent Directors Shares
IndependentDirectorsShares
4000 shares
CY2019Q4 akom Vest Rate Percentage
VestRatePercentage
0.25 pure
CY2021Q4 akom Vest Rate Percentage
VestRatePercentage
0.25 pure
CY2022Q4 akom Vest Rate Percentage
VestRatePercentage
0.25 pure
CY2020Q4 akom Vest Rate Percentage
VestRatePercentage
0.25 pure
CY2019Q4 akom Independent Directors Shares
IndependentDirectorsShares
4000 shares
CY2021Q1 akom Independent Directors Shares
IndependentDirectorsShares
4000 shares
CY2021Q4 akom Stock Option Aggregate Shares
StockOptionAggregateShares
18750 shares
CY2021Q4 akom Stock Option Aggregate Shares
StockOptionAggregateShares
8000 shares
CY2021Q4 akom Stock Option Aggregate Share
StockOptionAggregateShare
4000 shares
CY2021Q4 akom Stock Option Aggregate Shares
StockOptionAggregateShares
2000 shares
CY2022Q1 akom Stock Option Aggregate Shares
StockOptionAggregateShares
18750 shares
CY2022Q3 akom Stock Option Aggregate Shares
StockOptionAggregateShares
18750 shares
CY2022Q3 akom Stock Option Aggregate Shares
StockOptionAggregateShares
4000 shares
CY2022Q4 akom Stock Option Aggregate Shares
StockOptionAggregateShares
18750 shares
CY2022Q4 akom Stock Option Aggregate Shares
StockOptionAggregateShares
8000 shares
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
4000 shares
CY2023Q1 akom Stock Option Aggregate Shares
StockOptionAggregateShares
18750 shares
CY2023Q2 akom Stock Option Aggregate Shares
StockOptionAggregateShares
18750 shares
CY2023Q2 akom Stock Option Aggregate Shares
StockOptionAggregateShares
3627677 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4044230 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
264886 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1279688 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.8161
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
7.3194
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
805103 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.5605
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.9779
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2084791 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.6279
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.2566
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
51628 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.9456
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2136419 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.506
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.192
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
11000 shares
CY2022Q4 akom Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.507
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
805103 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.9779
CY2023 akom Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesVested
-144426 shares
CY2023 akom Average Granted Date Fair Value Vestedin Dollars Per Share
AverageGrantedDateFairValueVestedinDollarsPerShare
2.1351
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
671677 shares
CY2023Q4 akom Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.9691
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
51628 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.9456
akom Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesVested
-149922 shares
akom Average Granted Date Fair Value Vestedin Dollars Per Share
AverageGrantedDateFairValueVestedinDollarsPerShare
1.9885
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
573383 shares
CY2024Q2 akom Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.011
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
2.58
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
2.89
CY2018Q2 us-gaap Professional Fees
ProfessionalFees
1200000 usd
CY2020Q4 akom Refund Payment Amount
RefundPaymentAmount
8000000 cny
CY2020Q4 us-gaap Payments For Fees
PaymentsForFees
190000 cny
CY2022Q4 us-gaap Option Indexed To Issuers Equity Settlement Alternatives Shares At Fair Value
OptionIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue
25500000 shares
CY2024Q2 us-gaap Investments
Investments
15000000 usd
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
11.5
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2024Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
usd
CY2024Q2 us-gaap Revenues
Revenues
usd
CY2023Q2 us-gaap Revenues
Revenues
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Payments To Acquire Land Held For Use
PaymentsToAcquireLandHeldForUse
usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
usd
us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
usd
akom Proceeds From Subscribed Capital
ProceedsFromSubscribedCapital
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Revenues
Revenues
usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
usd
CY2023Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
usd
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
usd
akom Goodwill Addition
GoodwillAddition
usd
akom Accumulated Impairment Addition
AccumulatedImpairmentAddition
usd
akom Goodwill Addition Net
GoodwillAdditionNet
usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2024Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2024Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2024Q2 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2023Q2 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2024Q2 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
akom Service Income From Ejectt
ServiceIncomeFromEjectt
usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2023 akom Number Of Shares Forfeited Cancelledin Shares
NumberOfSharesForfeitedCancelledinShares
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023 akom Weighted Average Fair Value Per Share Forfeited Cancelled Per Shares
WeightedAverageFairValuePerShareForfeitedCancelledPerShares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
akom Number Of Shares Forfeited Cancelledin Shares
NumberOfSharesForfeitedCancelledinShares
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
akom Weighted Average Fair Value Per Share Forfeited Cancelled Per Shares
WeightedAverageFairValuePerShareForfeitedCancelledPerShares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001590496

Files In Submission

Name View Source Status
akom-20240630_cal.xml Edgar Link unprocessable
0001213900-24-080355-index-headers.html Edgar Link pending
0001213900-24-080355-index.html Edgar Link pending
0001213900-24-080355.txt Edgar Link pending
0001213900-24-080355-xbrl.zip Edgar Link pending
akom-20240630.xsd Edgar Link pending
ea0213989-10q_aerkomm.htm Edgar Link pending
ea021398901ex31-1_aerkomm.htm Edgar Link pending
ea021398901ex31-2_aerkomm.htm Edgar Link pending
ea021398901ex32-1_aerkomm.htm Edgar Link pending
ea021398901ex32-2_aerkomm.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
akom-20240630_pre.xml Edgar Link unprocessable
akom-20240630_lab.xml Edgar Link unprocessable
akom-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0213989-10q_aerkomm_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending